uridine monophosphate has been researched along with Malignant Melanoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Berg, C; Eigentler, T; Forschner, A; Geipel, A; Kofler, K; Kofler, L; Lipp, HP; Müller, A | 1 |
| Chin, B; Khattak, MA; Menon, LL | 1 |
| Drake, WP; Kopyta, LP; Levy, CC; Mardiney, MR | 1 |
3 other study(ies) available for uridine monophosphate and Malignant Melanoma
| Article | Year |
|---|---|
Simultaneous targeted therapy for metastatic melanoma and hepatitis C.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Benzimidazoles; Fluorenes; Hepatitis C, Chronic; Humans; Imidazoles; Melanoma; Oximes; Pyridones; Pyrimidinones; Skin Neoplasms; Sofosbuvir; Uridine Monophosphate | 2020 |
Safety of pembrolizumab while commencing treatment for hepatitis C with Harvoni (ledipasvir and sofosbuvir).
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antiviral Agents; Benzimidazoles; Clinical Decision-Making; Drug Therapy, Combination; Fluorenes; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Melanoma; Middle Aged; Neoplasm Staging; Sofosbuvir; Treatment Outcome; Uridine Monophosphate | 2018 |
Alterations in ribonuclease activities in the plasma, spleen, and thymus of tumor-bearing mice.
Topics: Adenocarcinoma; Adenosine Monophosphate; Animals; Cell Line; Cytidine Monophosphate; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Melanoma; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Neoplasm Proteins; Neoplasm Transplantation; Neoplasms, Experimental; Ribonucleases; Sarcoma, Experimental; Spleen; Thymus Gland; Transplantation, Homologous; Uridine Monophosphate | 1975 |